TNL Mediagene has been granted continued listing on the Nasdaq Capital Market subject to conditions. The company must demonstrate compliance with the minimum bid price requirement by September 21, 2026 and the stockholders' equity requirement by October 30, 2026. The Nasdaq Hearings Panel issued the decision on August 23, 2026, following a hearing on August 4, 2026. TNL Mediagene's ordinary shares will continue to trade under the symbol TNMG during the exception period, but failure to meet the conditions could result in delisting.
TNL Mediagene Ordinary SharesNasdaq listing conditions impose compliance deadlines; failure risks delisting.
